CGTX COGNITION THERAPEUTICS INC

Ownership history in Sigma Planning Corp  ·  9 quarters on record

This page tracks every 13F SEC filing in which Sigma Planning Corp reported a position in COGNITION THERAPEUTICS INC (CGTX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.01% (2024 Q4)
Avg. % of fund
0.01%
First filed
2023 Q4
Last filed
2025 Q4
Quarters held
9
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 ADDED 216,165 +89,075 +70.1% 0.01% $295K $1.35
2025 Q3 REDUCED 127,090 -20,900 -14.1% 0.00% $172K $1.35
2025 Q2 REDUCED 147,990 -460,400 -75.7% 0.00% $46K $0.31
2025 Q1 REDUCED 608,390 -6,100 -1.0% 0.01% $256K $0.42
2024 Q4 ADDED 614,490 +417,300 +211.6% 0.01% $431K $0.70
2024 Q3 ADDED 197,190 +25,050 +14.6% 0.00% $92K $0.47
2024 Q2 ADDED 172,140 +12,700 +8.0% 0.01% $286K $1.66
2024 Q1 ADDED 159,440 +130,890 +458.5% 0.01% $290K $1.82
2023 Q4 INITIATED 28,550 0.00% $53K
% of Fund (quarterly)    CGTX price (monthly, adj. close)
← Back to Sigma Planning Corp Holdings